rejuvant life tabs

Clearance of senescent cells for improved cognition

Latest articles

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

Charles Brenner: the journey from NR to Tru Niagen

Dr Charles Brenner, the developer of the intellectual property behind ChromaDex's Tru Niagen, on all things metabolism, NAD and NR clinical trials. Longevity.Technology: Following the...

Longevity investment firm announces acceleration programme

Call for future founders: longevity investment fund LongeVC announces in-house acceleration programme. LongeVC – a longevity investment group backed by an advisory board with solid...

The placenta: a limitless source of stem cells?

Part 1 of our exclusive interview with Celularity founder Dr Robert Hariri covers the discovery of placental pluripotent stem cells and the journey towards...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

Charles Brenner: the journey from NR to Tru Niagen

Dr Charles Brenner, the developer of the intellectual property behind ChromaDex's Tru Niagen, on all things metabolism, NAD and NR clinical trials. Longevity.Technology: Following the...

Longevity investment firm announces acceleration programme

Call for future founders: longevity investment fund LongeVC announces in-house acceleration programme. LongeVC – a longevity investment group backed by an advisory board with solid...
Rejuvant

Mayo Clinic proof-of-concept study shows that removal of senescent cells in the hippocampus of mice leads to improved cognitive responses.

It is no secret that with age a person becomes less focused, less attentive and more forgetful. Most neurodegenerative diseases have established correlations with aging, including Alzheimer’s disease (AD), Parkinson’s disease and amyotrophic lateral sclerosis (ALS), so affecting these diseases has an impact on Longevity.

Longevity.Technology: Senescence is an irreversible process where cells lose the power for division and growth with age. Entering senescence has protective anti-tumour purposes and is part of natural homeostasis, yet it has been strongly implicated in having a role in aging diseases and has been a focus of Longevity research.

One-way senescent cells are thought to have a detrimental biological effect is through the senescence-associated secretory phenotype (SASP). SASP is characterised by various biomarkers that reflect an increase in proinflammatory cytokines, chemokines and growth factors, as well as extracellular protease secretion.

Senescent cells tend to accumulate in the brain with age [1]; additionally, the removal of senescent cells has been identified to improve brain function in mouse models of neurodegenerative diseases such as AD [2] and ALS [3].

Professor James L Kirkland, whose team at the Mayo Clinic developed the idea that removing senescent cells may enhance health span, decided to follow-up on such findings and establish whether clearance of senescent cells alleviates cognitive functions.

The study began with single-nuclei and single-cell RNA sequencing of hippocampus samples from young and aged mice and found an age dependent increase in p16 containing senescent cells. P16, known as cyclin-dependent kinase inhibitor 2A, multiple tumour suppressor 1, is a protein that slows cell division by impacting G1 to S phase progression.

The characterisation of senescent cells was through SASP and cell populations found to have higher proportions of senescent cells were microglia and oligodendrocytes. Microglia are responsible for neuroprotection and homeostasis, while oligodendrocytes’ main function is to support and insulate neuron axons. There is a plethora of evidence in the literature establishing the role of damage to both of these glial cell types in neurodegeneration.

Elevant

 


 

“This opens up a potential therapeutic avenue for alleviating age-associated cognitive impairment…”

 


 

 

To follow this up, INK-ATTAC mice were studied for senescence removal effects. These genetically modified mice models can have senescent cells cleared upon treatment with the AP20187 compound, through specific p16 targeting. This compound was used for the control group. In parallel, a ‘senolytic cocktail’, containing Dasatinib and Quercetin (DQ), was administered to the experimental group of mice.

Both control and experiment decrease prevalence of p16 senescent cells almost exclusively in the microglial population. This then resulted in decreased microglial activation and a decrease in SASP expression.

Yet, more importantly both improved cognitive function in aged mice. Cognitive ability, particularly orientation and memory, was evaluated through the Stone T-maze test where mice must escape a maze with shallow water as an incentive. While there was no difference in the between the control and experimental group in time taken to exit the labyrinth, both control and experimental showed that fewer errors were made in finding the correct path relative to untreated mice [4].

Therefore, there is now proof-of-concept of the following: senescent microglia containing p16 can be selectively removed and result in amelioration of cognition. This opens up a potential therapeutic avenue for alleviating age-associated cognitive impairment.

Elevant

In an aging population is imperative that living longer is accompanied by health and purpose. Neurodegenerative diseases often shorten Longevity, healthspan and quality of life. Senolytic intervention could become a preventative solution to a problem currently lacking successful interventions.

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873891
[2] https://www.nature.com/articles/s41586-018-0543-y
[3] https://www.frontiersin.org/articles/10.3389/fnagi.2019.00042/full
[4] https://onlinelibrary.wiley.com/doi/10.1111/acel.13296

Image credit: Ken Wolter / Shutterstock
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

The placenta: a limitless source of stem cells?

Part 1 of our exclusive interview with Celularity founder Dr Robert Hariri covers the discovery of placental pluripotent stem cells and the journey towards...

Insulin – predictor of longevity

Body weight stands for far more than simple aesthetics – it is key for longevity. From a single cell to a fully functioning human adult,...

Juvenescence debuts ketosis longevity supplement drink

Biotech Juvenescence's new product Metabolic Switch is a drink that supports healthy aging and a healthy metabolism by generating a state of ketosis. It's been...

Targeting neurodegeneration with $82m Series A

Alchemab raises £60 million to advance novel platform for identifying disease-modifying antibody therapeutics for neurodegeneration, cancer and more. UK-based biotech Alchemab Therapeutics has secured a...
Supps report ad middle